Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
897.05
1.15
(0.13%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma receives Establishment Inspection Report for Kothur facility
>>
Natco Pharma informs about press release
>>
Natco Pharma surges on receiving final approval for generic version of TAMIFLU
>>
Natco Pharma informs about press release
>>
Natco Pharma receives final approval for generic version of TAMIFLU
>>
Natco Pharma submits copy of clarification
>>
Clarification sought from Natco Pharma
>>
Natco Pharma informs about press release
>>
Natco Pharma shines on receiving USFDA tentative approval for Sorafenib Tablets
>>
Natco Pharma receives USFDA tentative approval for Sorafenib Tablets
<<
<
38
39
40
...52
>
>>